Treatment of mice transplanted with muscle invasive bladder cancer cells using monoclonal anti-CD47 antibodies significantly reduced muscle invasive bladder cancer cells in a dose-dependent manner (Willingham et al., 2012). The gene discussed is CD47; the disease is urinary bladder cancer.